美国 · SEC FORM 4
NEONC TECHNOLOGIES HOLDINGS, INC.
NTHI · Nasdaq · CIK 0001979414 · Healthcare · Biotechnology
内部人信号
4 位买方 · 19 条买入交易行 · $996.6K 买入总额
为什么有这个信号？
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
哪些因素限制了当前分数？
- ⚠ 角色得分低 · 买入者中职位最高的是：President（CEO、董事长和持股 10% 以上的股东得分最低）
- ✓ Cluster breadth is broad · 4+ insiders
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度与集中度
Roles in the peak window: Chief Clinical Officer, Chief Scientific Officer, President. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
最新留档分数
- 74.4
- 74.2
- 74.1
- 73.9
- 73.7
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -24.0%
- 3M
- -35.6%
- 6M
- -48.9%
- 12M
- -77.0%
波动率与流动性
- 波动率
- 136.3%
- Beta
- —
- 平均每日成交额
- USD 553,904
估值
- 市值
- USD 72.1M
- P/E
- —
基本面
- 利润率
- —
- ROE
- —
- 细分行业
- Biotechnology
市场数据
价格数据截至：2026-10-11 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：市值 · 市值 = 申报文件封面所列的已发行股数 × 最新收盘价。股数日期：2026-08-10 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 757,739
- 上期报告
- 522,311
- 日均成交量
- 192,992
- 回补天数
- 3.9
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | Heshmatpour Amir F | 买入 (P) | Common Stock | 35,000 | USD 3.30 | USD 115,500 | SEC 申报 ↗ |
| 2026-09-14 | Heshmatpour Amir F | 买入 (P) | Common Stock | 15,000 | USD 3.96 | USD 59,400 | SEC 申报 ↗ |
| 2026-09-14 | GARNETT KEITHLY | 买入 (P) | Common Stock | 257 | USD 3.89 | USD 1,000 | SEC 申报 ↗ |
| 2026-09-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 5,242 | USD 3.82 | USD 20,024 | SEC 申报 ↗ |
| 2026-09-11 | CHEN THOMAS C | 买入 (P) | Common Stock | 5,556 | USD 3.60 | USD 20,002 | SEC 申报 ↗ |
| 2026-09-11 | Heshmatpour Amir F | 买入 (P) | Common Stock | 37,000 | USD 3.67 | USD 135,790 | SEC 申报 ↗ |
| 2026-08-18 | CHEN THOMAS C | 买入 (P) | Common Stock | 12,757 | USD 5.49 | USD 70,036 | SEC 申报 ↗ |
| 2026-08-18 | Heshmatpour Amir F | 买入 (P) | Common Stock | 9,000 | USD 5.54 | USD 49,860 | SEC 申报 ↗ |
| 2026-08-17 | CHEN THOMAS C | 买入 (P) | Common Stock | 2,472 | USD 4.04 | USD 9,987 | SEC 申报 ↗ |
| 2026-08-17 | CHEN THOMAS C | 买入 (P) | Common Stock | 2,472 | USD 4.04 | USD 9,987 | SEC 申报 ↗ |
| 2026-08-17 | Heshmatpour Amir F | 买入 (P) | Common Stock | 3,000 | USD 4.37 | USD 13,110 | SEC 申报 ↗ |
| 2026-08-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 33,787 | USD 3.85 | USD 130,080 | SEC 申报 ↗ |
| 2026-08-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 33,787 | USD 3.85 | USD 130,080 | SEC 申报 ↗ |
| 2026-08-14 | Heshmatpour Amir F | 买入 (P) | Common Stock | 12,000 | USD 3.79 | USD 45,480 | SEC 申报 ↗ |
| 2026-05-01 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 4.16 | USD 41,600 | SEC 申报 ↗ |
Form 4 申报证据
33 transaction lines in the latest 365-day window; 101 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | GARNETT KEITHLY | 卖出 (S) | Common Stock | 5,000 | USD 3.36 | USD 16,800 | SEC 申报 ↗ |
| 2026-09-15 | Heshmatpour Amir F | 买入 (P) | Common Stock | 35,000 | USD 3.30 | USD 115,500 | SEC 申报 ↗ |
| 2026-09-14 | Heshmatpour Amir F | 买入 (P) | Common Stock | 15,000 | USD 3.96 | USD 59,400 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-09-15 | GARNETT KEITHLY | 卖出 (S) | Common Stock | 5,000 | USD 3.36 | USD 16,800 | SEC 申报 ↗ |
| 2026-09-15 | Heshmatpour Amir F | 买入 (P) | Common Stock | 35,000 | USD 3.30 | USD 115,500 | SEC 申报 ↗ |
| 2026-09-14 | Heshmatpour Amir F | 买入 (P) | Common Stock | 15,000 | USD 3.96 | USD 59,400 | SEC 申报 ↗ |
| 2026-09-14 | GARNETT KEITHLY | 买入 (P) | Common Stock | 257 | USD 3.89 | USD 1,000 | SEC 申报 ↗ |
| 2026-09-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 5,242 | USD 3.82 | USD 20,024 | SEC 申报 ↗ |
| 2026-09-11 | CHEN THOMAS C | 买入 (P) | Common Stock | 5,556 | USD 3.60 | USD 20,002 | SEC 申报 ↗ |
| 2026-09-11 | Heshmatpour Amir F | 买入 (P) | Common Stock | 37,000 | USD 3.67 | USD 135,790 | SEC 申报 ↗ |
| 2026-08-18 | CHEN THOMAS C | 买入 (P) | Common Stock | 12,757 | USD 5.49 | USD 70,036 | SEC 申报 ↗ |
| 2026-08-18 | Heshmatpour Amir F | 买入 (P) | Common Stock | 9,000 | USD 5.54 | USD 49,860 | SEC 申报 ↗ |
| 2026-08-17 | CHEN THOMAS C | 买入 (P) | Common Stock | 2,472 | USD 4.04 | USD 9,987 | SEC 申报 ↗ |
| 2026-08-17 | CHEN THOMAS C | 买入 (P) | Common Stock | 2,472 | USD 4.04 | USD 9,987 | SEC 申报 ↗ |
| 2026-08-17 | Heshmatpour Amir F | 买入 (P) | Common Stock | 3,000 | USD 4.37 | USD 13,110 | SEC 申报 ↗ |
| 2026-08-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 33,787 | USD 3.85 | USD 130,080 | SEC 申报 ↗ |
| 2026-08-14 | CHEN THOMAS C | 买入 (P) | Common Stock | 33,787 | USD 3.85 | USD 130,080 | SEC 申报 ↗ |
| 2026-08-14 | Heshmatpour Amir F | 买入 (P) | Common Stock | 12,000 | USD 3.79 | USD 45,480 | SEC 申报 ↗ |
| 2026-07-10 | SHOMALI NASIM | 奖励／授予 (A) | Common Stock | 50,000 | USD — | USD — | SEC 申报 ↗ |
| 2026-05-01 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 4.16 | USD 41,600 | SEC 申报 ↗ |
| 2026-04-28 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 4.52 | USD 45,200 | SEC 申报 ↗ |
| 2026-04-24 | CHEN THOMAS C | 买入 (P) | Common Stock | 10,000 | USD 4.80 | USD 48,000 | SEC 申报 ↗ |
| 2026-04-23 | Neman-Ebrahim Yousha | 买入 (P) | Common Stock | 500 | USD 4.88 | USD 2,440 | SEC 申报 ↗ |
| 2026-04-23 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 4.90 | USD 49,000 | SEC 申报 ↗ |
| 2026-04-10 | CHEN THOMAS C | 买入 (P) | Common Stock | 948 | USD 5.17 | USD 4,901 | SEC 申报 ↗ |
| 2026-04-10 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 4.90 | USD 49,000 | SEC 申报 ↗ |
| 2026-04-09 | SUH, DAVID JR. | 买入 (P) | Common Stock | 200 | USD 5.00 | USD 1,000 | SEC 申报 ↗ |
| 2026-04-09 | Heshmatpour Amir F | 买入 (P) | Common Stock | 5,000 | USD 5.19 | USD 25,950 | SEC 申报 ↗ |
| 2026-04-08 | Heshmatpour Amir F | 买入 (P) | Common Stock | 10,000 | USD 5.61 | USD 56,100 | SEC 申报 ↗ |
| 2026-04-06 | Heshmatpour Amir F | 买入 (P) | Common Stock | 5,000 | USD 6.32 | USD 31,600 | SEC 申报 ↗ |
| 2026-04-02 | Heshmatpour Amir F | 买入 (P) | Common Stock | 20,000 | USD 6.09 | USD 121,800 | SEC 申报 ↗ |
| 2025-11-24 | Heshmatpour Amir F | 买入 (P) | Common Stock | 6,000 | USD 6.51 | USD 39,060 | SEC 申报 ↗ |
| 2025-11-21 | Heshmatpour Amir F | 买入 (P) | CommonStock | 20,000 | USD 5.98 | USD 119,600 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | NTHI |
| CIK | 0001979414 |
| 行业 | Healthcare |
| 细分行业 | Biotechnology Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 101 transaction lines from 2025-03-26 to 2026-09-15 47 P purchase lines · 21 S sale lines · 33 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.